IR-Med Inc. (IRME)
PNK · Healthcare · Medical Devices
Closing price as of 2026-09-10 · Source: TEK2day Finance
Key Metrics
About IR-Med Inc.
IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company's development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulcers in lower limb skin and underlying tissue caused by prolonged pressure on the sole of diabetic patients; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children. IR-Med Inc. is headquartered in Rosh Pinna, Israel.
Quarterly Financials
| Metric | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (601K) | (324K) | (253K) | (286K) |
| Net Income | (598K) | (278K) | (773K) | (701K) |
| Diluted EPS | $-0.01 | N/A | $-0.01 | $-0.01 |
Annual Financials
| Metric | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (3.7M) | (4.8M) | (4.9M) | (1.9M) |
| Net Income | (3.7M) | (4.7M) | (4.9M) | (1.9M) |
| Diluted EPS | $-0.06 | $-0.07 | $-0.07 | $-0.03 |